Xsphera Biosciences
Pre-clinicalAnimal models have proven to be insufficient for predicting human response to cancer drugs. Xsphera overcomes these limitations with a human tissue-based platform that accurately captures the dynamic response of the tumor microenvironment across the diversity of patients.
Founded
2019
Focus
OncologyImmunology
About
Animal models have proven to be insufficient for predicting human response to cancer drugs. Xsphera overcomes these limitations with a human tissue-based platform that accurately captures the dynamic response of the tumor microenvironment across the diversity of patients.
Funding History
2Total raised: $20.2M
Series A$17MAgent CapitalFeb 15, 2023
Seed$3.2MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2019
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile